RSK2 promotes melanoma cell proliferation and vemurafenib resistance via upregulating cyclin D1

Hai-zhou Wu(Central South University), Yan Cheng(Central South University)
Frontiers in Pharmacology
September 20, 2022
Cited by 8


Related Papers